Wall Street expects a year-over-year increase in earnings on higher revenues when ResMed (RMD) reports results for the quarter ended March 2025. While this widely-known consensus outlook is ...

Shares of ResMed Inc. RMD shed 1.16% to $211.49 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 1132 ET – Novo Nordisk’s American depositary receipts ...

Sleep software company ResMed, which is based in San Diego, ranked number nine on LinkedIn's list. ResMed makes medical devices for sleep disorders and employes around 3500 people in Australia.

Healthcare stocks exposed to the US were buoyant on Monday: CSL jumped 2.4 per cent to $243.67, Ansell rose 1.2 per cent to $29.39, Resmed gained 0.6 per cent to $33.80, and Cochlear was also up 0 ...

We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Erasca Inc. (NASDAQ:ERAS) stands against ...

It operates through the following segments: Non-life Run-off, Atrium, StarStone, and Other. The Non-life Run-off segment operates through its subsidiaries that run off their property and casualty ...